amitraz has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adelaïde, J; Bertucci, F; Carbuccia, N; Chaffanet, M; Dalenc, F; Garnier, S; Goncalves, A; Guille, A; Isambert, N; Levy, C; Mamessier, E; Pakradouni, J; Robert, M; Sabatier, R; Sfumato, P; Vicier, C | 1 |
Chan, PK; Hung, CC; Ueng, TH; Wang, HW | 1 |
1 trial(s) available for amitraz and Breast Neoplasms
Article | Year |
---|---|
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
Topics: Angiogenesis Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Circulating Tumor DNA; Female; Humans; Mutation; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Toluidines | 2022 |
1 other study(ies) available for amitraz and Breast Neoplasms
Article | Year |
---|---|
Effects of amitraz on cytochrome P450-dependent monooxygenases and estrogenic activity in MCF-7 human breast cancer cells and immature female rats.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Estradiol; Estrogen Receptor Modulators; Female; Humans; Injections, Intraperitoneal; Insecticides; Liver; Mixed Function Oxygenases; Organ Size; Peroxidase; Rats; Rats, Wistar; Receptors, Estrogen; Toluidines; Uterus | 2004 |